BWX Technologies (NYSE:BWXT – Get Free Report) is anticipated to post its Q2 2026 results after the market closes on Monday, August 3rd. Analysts expect the company to announce earnings of $1.01 per share and revenue of $903.9180 million for the quarter. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Monday, August 3, 2026 at 5:00 PM ET.
BWX Technologies (NYSE:BWXT – Get Free Report) last issued its earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.20. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The company had revenue of $860.22 million during the quarter, compared to analysts’ expectations of $837.47 million. During the same period in the prior year, the business posted $0.91 EPS. BWX Technologies’s quarterly revenue was up 26.1% compared to the same quarter last year. On average, analysts expect BWX Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
BWX Technologies Price Performance
BWXT opened at $174.48 on Monday. The stock’s 50 day simple moving average is $191.42 and its 200 day simple moving average is $202.84. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. BWX Technologies has a 1 year low of $143.07 and a 1 year high of $241.82. The firm has a market cap of $15.98 billion, a price-to-earnings ratio of 46.65, a PEG ratio of 2.98 and a beta of 0.74.
BWX Technologies Announces Dividend
Analysts Set New Price Targets
A number of analysts have recently weighed in on the company. Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of BWX Technologies in a research note on Friday, May 22nd. Truist Financial upped their price target on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a report on Monday, May 11th. Zacks Research cut shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Finally, Wells Fargo & Company assumed coverage on shares of BWX Technologies in a report on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $228.00.
View Our Latest Analysis on BWXT
Insider Activity at BWX Technologies
In related news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the sale, the chief executive officer owned 202,491 shares of the company’s stock, valued at $41,472,181.71. This trade represents a 4.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the sale, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at $1,440,477. The trade was a 25.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in BWXT. Wedbush Securities Inc. raised its holdings in BWX Technologies by 4.3% in the 4th quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company’s stock worth $218,000 after purchasing an additional 52 shares in the last quarter. Guggenheim Capital LLC boosted its stake in shares of BWX Technologies by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 2,598 shares of the technology company’s stock valued at $449,000 after purchasing an additional 55 shares in the last quarter. Corient Private Wealth LLC increased its position in shares of BWX Technologies by 1.2% during the second quarter. Corient Private Wealth LLC now owns 5,880 shares of the technology company’s stock valued at $847,000 after buying an additional 69 shares during the period. Vanguard Personalized Indexing Management LLC increased its position in shares of BWX Technologies by 1.0% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 9,331 shares of the technology company’s stock valued at $1,613,000 after buying an additional 88 shares during the period. Finally, AlTi Global Inc. raised its stake in BWX Technologies by 1.6% in the fourth quarter. AlTi Global Inc. now owns 5,884 shares of the technology company’s stock worth $1,017,000 after buying an additional 90 shares in the last quarter. 94.39% of the stock is currently owned by institutional investors.
BWX Technologies Company Profile
BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.
Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.
Further Reading
- Five stocks we like better than BWX Technologies
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for BWX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BWX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
